Showing results (1121-1130 of 1,823) with videos related to

Sort By:
Pageof 183
Transplantation and Cellular Therapy|December 9, 2022
Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN TrialsSaurabh Chhabra, Natalie Callander, Nicole L Watts, et al.
Transplantation and Cellular Therapy|July 30, 2021
Myeloablative Fractionated Busulfan With Fludarabine in Older Patients: Long Term Disease-Specific Outcomes of a Prospective Phase II Clinical TrialRohtesh S Mehta, Roland Bassett, Julianne Chen, et al.
Transplantation and Cellular Therapy|July 30, 2021
Increased Infections and Delayed CD4+ T Cell but Faster B Cell Immune Reconstitution after Post-Transplantation Cyclophosphamide Compared to Conventional GVHD Prophylaxis in Allogeneic TransplantationFarhad Khimani, Peter Ranspach, Hany Elmariah, et al.
Transplantation and Cellular Therapy|October 4, 2020
Acute Respiratory Failure Outcomes in Patients with Hematologic Malignancies and Hematopoietic Cell Transplant: A Secondary Analysis of the EFRAIM StudyLaveena Munshi, Michael Darmon, Marcio Soares, et al.
Transplantation and Cellular Therapy|May 16, 2022
Effect of Multiple HLA Locus Mismatches on Outcomes after Single Cord Blood TransplantationJunya Kanda, Shigeki Hirabayashi, Hisayuki Yokoyama, et al.
Transplantation and Cellular Therapy|May 24, 2022
Outcomes of Autologous Hematopoietic Cell Transplantation in Older Patients with Diffuse Large B-Cell LymphomaPashna N Munshi, Yue Chen, Kwang W Ahn, et al.
Transplantation and Cellular Therapy|May 19, 2022
eHealth-Generated Patient Data in an Outpatient Setting after Hematopoietic Stem Cell Transplantation: A Scoping ReviewJolien Van Opstal, Aaron T Zhao, Samantha J Kaplan, et al.
Transplantation and Cellular Therapy|May 20, 2022
Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 YearsMeagan V Lew, Yi Ren, Yen P Lowder, et al.
Transplantation and Cellular Therapy|May 22, 2022
Letermovir Discontinuation at Day 100 After Allogeneic Stem Cell Transplant Is Associated With Increased CMV-Related MortalityLawrence Wayne Liu, Alicia Yn, Feng Gao, et al.
Transplantation and Cellular Therapy|November 14, 2021
Retrospective Analysis of Autologous Stem Cell Transplantation for AL Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell TransplantationShin-Ichi Fuchida, Koji Kawamura, Kazutaka Sunami, et al.
Pageof 183